GLP-1 Receptor Agonists Linked to Lower Mortality, Amputation Rate in PAD and Type 2 Diabetes

FRIDAY, July 10, 2026-- For patients with peripheral artery disease (PAD) and type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with lower rates of mortality, hospitalization, revascularization, and amputation...